SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹43,886 Cr | ₹38,654 Cr | ₹33,498 Cr | ₹32,838 Cr | ₹29,066 Cr |
What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Revenue |
---|---|
Mar2023 | ₹43,886 Cr |
Mar2022 | ₹38,654 Cr |
Mar2021 | ₹33,498 Cr |
Mar2020 | ₹32,838 Cr |
Mar2019 | ₹29,066 Cr |
How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹43,886 Cr | 13.53 | |
Mar2022 | ₹38,654 Cr | 15.39 | |
Mar2021 | ₹33,498 Cr | 2.01 | |
Mar2020 | ₹32,838 Cr | 12.98 | |
Mar2019 | ₹29,066 Cr | - |
Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹365,065.5 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,300.0 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,202.0 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,035.0 Cr | -3.7% | -1.4% | 26% | Stock Analytics | |
MANKIND PHARMA | ₹87,328.3 Cr | -6.6% | -6.6% | NA | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.2% |
-6.1% |
55.7% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses